MedPath

Effect of Different Ultrasound Doses on Median Nerve Conduction Parameters

Not Applicable
Recruiting
Conditions
Entrapment Neuropathies
Interventions
Device: Pulsed Ultrasound Therapy
Registration Number
NCT05233488
Lead Sponsor
Cairo University
Brief Summary

The current study investigates the effect of different doses of pulses ultrasound therapy on different nerve conduction parameters of the median nerve in healthy volunteering subjects.

Detailed Description

In the current study, we apply pulsed ultrasound therapy on median nerves of healthy volunteer subjects, at 1 W/cm2 10% duty cycle, 3 W/cm2 10% duty cycle, 1 W/cm2 50% duty cycle, and 3 w/cm2 50% duty cycle. Parameters of median nerve conduction study, Latency, amplitude, area, duration and forearm NCV are recorded before and after application of ultrasound therapy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. 120 hands of 60 subjects of both genders with age range 18: 24 years.
  2. Subjects assigned will be apparently healthy subjects with no neurological or neuromuscular history affecting the upper limb.
Exclusion Criteria
  1. Peripheral polyneuropathy.
  2. Diabetes mellitus.
  3. Previous surgeries or median and/or ulnar nerve release.
  4. Cervical radiculopathy.
  5. Median or ulnar entrapment neuropathies.
  6. Previous or current pregnancies.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intermediate US dosePulsed Ultrasound TherapyPulsed US, 1 W/cm2, 50% duty cycle.
Low US dosePulsed Ultrasound TherapyPulsed US, 1 W/cm2, 10% duty cycle.
High US dosePulsed Ultrasound TherapyPulsed US, 3 W/cm2, 10% duty cycle.
Higher US dosePulsed Ultrasound TherapyPulsed US, 3 W/cm2, 50% duty cycle.
Primary Outcome Measures
NameTimeMethod
CMAP distal latencyImmediately after application

msecond

CMAP amplitudeImmediately after application

mV

CMAP durationImmediately after application

msecond

Nerve conduction studyImmediately after application

m/sec.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo University

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath